Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,916,000 | 7,841,000 | 5,840,000 | 4,871,000 | 5,664,000 |
| Marketable Securities | 160,000 | 180,000 | 20,000 | 244,000 | 148,000 |
| Inventories | 5,667,000 | 5,337,000 | 5,424,000 | 5,292,000 | 5,051,000 |
| Other current assets | 12,650,000 | 12,236,000 | 12,153,000 | 12,094,000 | 11,976,000 |
| TOTAL | $25,393,000 | $25,594,000 | $25,054,000 | $22,501,000 | $22,839,000 |
| Non-Current Assets | |||||
| PPE Net | 10,833,000 | 10,616,000 | 10,502,000 | 9,700,000 | 9,624,000 |
| Intangibles | 60,486,000 | 58,812,000 | 58,137,000 | 57,626,000 | 58,286,000 |
| Other Non-Current Assets | 7,628,000 | 7,271,000 | 7,426,000 | 6,259,000 | 5,794,000 |
| TOTAL | $78,947,000 | $76,699,000 | $76,065,000 | $73,585,000 | $73,704,000 |
| Total Assets | $104,340,000 | $102,293,000 | $101,119,000 | $96,086,000 | $96,543,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,067,000 | 6,050,000 | 5,129,000 | 5,372,000 | 4,556,000 |
| Accounts payable and accrued liabilities | 20,463,000 | 19,699,000 | 3,267,000 | 20,542,000 | 19,738,000 |
| TOTAL | $28,566,000 | $28,901,000 | $30,542,000 | $28,588,000 | $26,375,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,225,000 | 27,259,000 | 22,365,000 | 22,225,000 | 24,329,000 |
| Other Non-Current Liabilities | 4,583,000 | 4,994,000 | 5,315,000 | 4,532,000 | 4,877,000 |
| TOTAL | $36,176,000 | $35,891,000 | $31,411,000 | $30,277,000 | $32,752,000 |
| Total Liabilities | $64,742,000 | $64,792,000 | $61,953,000 | $58,865,000 | $59,127,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 388,000 | 388,000 | 387,000 | 387,000 |
| Retained earnings | 1,847,000 | -212,000 | 1,502,000 | -434,000 | -234,000 |
| Other shareholders' equity | 2,078,000 | 2,075,000 | 1,912,000 | 2,078,000 | 2,076,000 |
| TOTAL | $39,512,000 | $37,445,000 | $39,143,000 | $37,197,000 | $37,392,000 |
| Total Liabilities And Equity | $104,254,000 | $102,237,000 | $101,096,000 | $96,062,000 | $96,519,000 |